Is AL721 really a lipid fluidity modulating agent?
Offner
F A
FA
Traill
K N
KN
Winter
U
U
Wick
G
G
D000998:Antiviral Agents / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D005989:Glycerides / Q000494:pharmacology*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008560:Membrane Fluidity / Q000187:drug effects*; D010713:Phosphatidylcholines / Q000494:pharmacology*; D010714:Phosphatidylethanolamines / Q000494:pharmacology*
D000998:Antiviral Agents; D004338:Drug Combinations; D005989:Glycerides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; C046637:neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination